2seventy bio Inc (TSVT) Actualités

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC 14D9 - Solicitation, recommendation statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results

Entered into definitive merger agreement to be acquired by Bristol Myers Squibb at a price of $5.00 per share in an all-cash transaction;...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC14D9C - Written communication relating to third party tender offer

Form SC14D9C - Written communication relating to third party tender offer

Form SC14D9C - Written communication relating to third party tender offer

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. PR Newswire NEW YORK, March 11, 2025 NEW YORK, March 11, 2025...

Form SC14D9C - Written communication relating to third party tender offer

Form 8-K - Current report